Skip to main content
. 2020 Jan 30;33(1):34–42. doi: 10.1089/jamp.2019.1537

FIG. 2.

FIG. 2.

Plasma FP (left panels) and plasma salmeterol (right panels) versus time data after administration of FP/S to healthy subjects (T [closed circles] or R [open circles]) in studies 1, 2, and 3. Data presented are arithmetic mean plasma concentration (semilog scale) (n = 62–66). FP/S, fluticasone propionate/salmeterol.